2025. PO86 | Emicizumab in patients with moderate hemophilia A and severe bleeding phenotype: single-center real-world experience: A.L. Faccini, M. Biglietto, S. Sorella, E. Crisanti, M. Antonacci, R. Mormile, R. Ciciani, E. Baldacci, C. Santoro, S. Ligia | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy. Bleeding, Thrombosis and Vascular Biology. 4, s1 (Aug. 2025). DOI:https://doi.org/10.4081/btvb.2025.355.